SYRS - Syros Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SYRS is currently covered by 5 analysts with an average price target of $32.63. This is a potential upside of $32.42 (15438.1%) from yesterday's end of day stock price of $0.21.

Syros Pharmaceuticals's activity chart (see below) currently has 36 price targets and 54 ratings on display. The stock rating distribution of SYRS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.15% with an average time for these price targets to be met of 267.13 days.

Highest price target for SYRS is $6, Lowest price target is $4, average price target is $32.63.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 01-Nov-2024. First documented stock forecast 18-Jul-2016.

Currently out of the existing stock ratings of SYRS, 20 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$3.39 (129.89%)

$6

1 months 17 days ago
(01-Nov-2024)

2/12 (16.67%)

$3.73 (164.32%)

30

Buy

$5

$2.39 (91.57%)

$7

4 months 5 days ago
(13-Aug-2024)

2/11 (18.18%)

$3.08 (160.42%)

82

Buy

$4

$1.39 (53.26%)

$15

4 months 5 days ago
(13-Aug-2024)

1/5 (20%)

$2.08 (108.33%)

1063

Buy

$13

$5.4 (71.05%)

$15

1 years 9 months 15 days ago
(03-Mar-2023)

1/4 (25%)

$9.07 (230.79%)

155

Buy

$19

$14.86 (358.94%)

$23

2 years 6 months 10 days ago
(08-Jun-2022)

1/3 (33.33%)

$2.24 (59.78%)

17

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SYRS (Syros Pharmaceuticals) average time for price targets to be met?

On average it took 267.13 days on average for the stock forecasts to be realized with a an average price target met ratio 39.15

Which analyst has the current highest performing score on SYRS (Syros Pharmaceuticals) with a proven track record?

ZEGBEH JALLAH

Which analyst has the current lower performing score on SYRS (Syros Pharmaceuticals) with a proven track record?

MATT CROSS

Which analyst has the most public recommendations on SYRS (Syros Pharmaceuticals)?

Zegbeh Jallah works at CAPITAL ONE and has 21 price targets and 15 ratings on SYRS

Which analyst is the currently most bullish on SYRS (Syros Pharmaceuticals)?

Leah Rush Cann with highest potential upside - $14.86

Which analyst is the currently most reserved on SYRS (Syros Pharmaceuticals)?

Zegbeh Jallah with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?